Geneos Wealth Management’s First Trust Multi Cap Value AlphaDEX Fund FAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25K Hold
246
﹤0.01% 1724
2026
Q1
$23.3K Sell
246
-64
-21% -$6.07K ﹤0.01% 1713
2025
Q4
$27.6K Sell
310
-318
-51% -$27.8K ﹤0.01% 1616
2025
Q3
$54.8K Hold
628
﹤0.01% 1352
2025
Q2
$51K Buy
628
+382
+155% +$29.6K ﹤0.01% 1559
2025
Q1
$19.6K Hold
246
﹤0.01% 1961
2024
Q4
$20.3K Hold
246
﹤0.01% 1718
2024
Q3
$20.8K Hold
246
﹤0.01% 1548
2024
Q2
$19.4K Hold
246
﹤0.01% 1363
2024
Q1
$20.3K Hold
246
﹤0.01% 1359
2023
Q4
$19.2K Hold
246
﹤0.01% 1371
2023
Q3
$17.1K Buy
246
+110
+81% +$7.99K ﹤0.01% 1428
2023
Q2
$9.64K Hold
136
﹤0.01% 1586
2023
Q1
$9.48K Hold
136
﹤0.01% 1562
2022
Q4
$9.36K Buy
+136
New +$9.27K ﹤0.01% 1546

Other funds holding FAB

Geneos Wealth Management's FAB Position: Q2 2026 in Review

Geneos Wealth Management held its First Trust Multi Cap Value AlphaDEX Fund (FAB) position steady in Q2 2026 at 246 shares worth $25K. The position accounts for ﹤0.01% of the portfolio, ranked #1724.

Geneos Wealth Management first reported a position in FAB in Q4 2022 and has held it in 15 quarters since. The position peaked at $54.8K in Q3 2025. 66 funds tracked by Wall St. Rank hold FAB as of Q2 2026.

  • Geneos Wealth Management held 246 shares of First Trust Multi Cap Value AlphaDEX Fund worth $25K as of Q2 2026.
  • Geneos Wealth Management left its First Trust Multi Cap Value AlphaDEX Fund share count unchanged in Q2 2026.
  • First Trust Multi Cap Value AlphaDEX Fund made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1724 holding.
  • Geneos Wealth Management first reported a position in First Trust Multi Cap Value AlphaDEX Fund in Q4 2022 and has held it in 15 quarters since.
  • Geneos Wealth Management's First Trust Multi Cap Value AlphaDEX Fund position peaked at $54.8K in Q3 2025.
  • 66 funds tracked by Wall St. Rank held First Trust Multi Cap Value AlphaDEX Fund as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.